Erythromycin: a microbial and clinical perspective after 30 years of clinical use (1). (Q37904600)

25 August 2017

Erythromycin: a microbial and clinical perspective after 30 years of clinical use (1). (English)

1 reference

25 August 2017

1 reference

1

J A Washington

1 reference

25 August 2017

W R Wilson

2

1 reference

PubMed ID

3974301

25 August 2017

language of work or name

English

0 references

publication date

1 March 1985

1 reference

25 August 2017

1 reference

25 August 2017

60

1 reference

25 August 2017

3

1 reference

25 August 2017

189-203

1 reference

The antibacterial action of erythromycin

25 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960219-5

Activity of erythromycin against Staphylococcus aureus.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960219-5

Susceptibility of Bacterium actinomycetem comitans to 45 antibiotics

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960219-5

In vitro antimicrobial susceptibility of Actinobacillus actinomycetemcomitans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960219-5

Antimicrobial in vitro susceptibility of actinomyces israelii and arachnia propionica.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960219-5

A study in vitro of the sensitivity to antibiotics of Bacteroides fragilis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960219-5

The effect of carbon dioxide on the sensitivity of Bacteroides fragilis to certain antibiotics in vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960219-5

In Vitro Antimicrobial Susceptibility of Anaerobic Bacteria Isolated from Clinical Specimens

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960219-5

Susceptibility of Bacteroides melaninogenicus to 45 antibiotics.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960219-5

Antimicrobial susceptibilities of bacteria associated with periodontal disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960219-5

Antimicrobial Susceptibility of Bordetella pertussis Strains Isolated from 1960 to 1981

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960219-5

Branhamella catarrhalis: antibiotic susceptibility and beta-lactamase production.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960219-5

Susceptibility of Campylobacter fetus to twenty-two antimicrobial agents

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960219-5

Susceptibility of Campylobacter fetus subsp. jejuni to Twenty Antimicrobial Agents

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960219-5

Antimicrobial susceptibility of Campylobacter jejuni with special reference to resistance patterns of Canadian isolates

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960219-5

Susceptibility pattern of Campylobacter jejuni from human and animal origins to different antimicrobial agents

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960219-5

Antimicrobial susceptibility of Capnocytophaga

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960219-5

In vitro susceptibility of Capnocytophaga strains to 18 antimicrobial agents

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960219-5

Antimicrobial activity of several antibiotics and a sulfonamide against Chlamydia trachomatis organisms in cell culture

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960219-5

Relative resistance to erythromycin in Chlamydia trachomatis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960219-5

In vitro susceptibility of Clostridium difficile isolates from patients with antibiotic-associated diarrhea or colitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960219-5

The sensitivity of diphtheria bacilli to eight antibiotics

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960219-5

Activity of penicillin, erythromycin, and cephalosporins against isolates of Coryntbaeterimm diphtheriae from cutaneous lesions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960219-5

Susceptibility of human skin aerobic diphtheroids to antimicrobial agents in vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960219-5

In vitro susceptibility of Bacteroides corrodens and Eikenella corrodens to ten chemotherapeutic agents

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960219-5

Antimicrobial susceptibility of flavobacteria

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960219-5

In-vitro sensitivity of Elavobacterium meningosepticum to antimicrobial agents

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960219-5

In vitro susceptibilities of nonfermentative gram-negative bacilli other than Pseudomonas aeruginosa to 32 antimicrobial agents.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960219-5

Antibiotic Susceptibility of Haemophilus vaginalis (Corynebacterium vaginale) to 21 Antibiotics

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960219-5

In vitro activity of seventeen antimicrobial agents againstGardnerella vaginalis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960219-5

Sensitivity of Haemophilus influenzae to Antibiotics

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960219-5

Antimicrobial susceptibility of Haemophilus influenzae

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960219-5

Hemophilus influenzae type B susceptibility to 17 antibiotics

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960219-5

Susceptibility of Pneumococci and Haemophilus influenzae to Antibacterial Agents

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960219-5

Antimicrobial Susceptibility of Haemophilus parainfluenzae

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960219-5

Haemophilus aphrophilus infections: clinical and bacteriologic studies.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960219-5

A comparison of the in vitro activity of rosa-micin, erythromycin, clindamycin, metroni-dazole and ornidazole against Haemophilus ducreyl, including β-lactamase producing strains

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960219-5

Antimicrobial susceptibility of 103 strains of Haemophilus ducreyi isolated in Johannesburg

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960219-5

In Vitro Susceptibility of Legionella pneumophila, Serogroups I-IV

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960219-5

The rickettsia-like organisms TATLOCK (1943) and HEBA (1959): bacteria phenotypically similar to but genetically distinct from Legionella pneumophila and the WIGA bacterium

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960219-5

Susceptibility of Legionella pneumophila to twenty antimicrobial agents

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960219-5

Susceptibility of Pittsburgh pneumonia agent (Legionella micdadei) and other newly recognized members of the genus Legionella to nineteen antimicrobial agents

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960219-5

Antibiotic Susceptibility of Clinical Isolates of Listeria monocytogenes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960219-5

In vitro susceptibility of Mycobacterium marinum to eight antimicrobial agents

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960219-5

In-Vitro Activity of Erythromycin against Atypical Mycobacteria

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960219-5

Rapidly growing mycobacteria: testing of susceptibility to 34 antimicrobial agents by broth microdilution

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960219-5

Susceptibility of organisms in the Mycobacterium fortuitum complex to antituberculous and other antimicrobial agents

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960219-5

Disk diffusion testing of susceptibility of Mycobacterium fortuitum and Mycobacterium chelonei to antibacterial agents

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960219-5

The effect of antibiotics on Mycoplasma pneumoniae in vitro and in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960219-5

In Vitro Activity of Rosamicin, Josamycin, Erythromycin, and Clindamycin Against β-Lactamase-Negative and β-Lactamase-Positive Strains of Neisseria gonorrhoeae

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960219-5

In vitro susceptibility of 50 non-beta-lactamase-producing Neisseria gonorrhoeae strains to 12 antimicrobial agents

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960219-5

CHANGING SUSCEPTIBILITY OF MENINGOCOCCI TO ANTIMICROBIAL AGENTS.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960219-5

Antimicrobial Susceptibility of Nocardia Species

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960219-5

Susceptibility of Nocardia asteroides to 45 Antimicrobial Agents In Vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960219-5

Susceptibility of Nocardia asteroides to 46 antibiotics, including 22 beta-lactams

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960219-5

Antibiotic susceptibilities of human isolates of Pasteurella multocida

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960219-5

Antimicrobiol susceptibility of Propinibacterium acnes and related microbial species

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960219-5

Susceptibility of Propionibacterium acnes clinical isolates to 22 antimicrobial agents

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960219-5

Sensitivity of Rothia dentocariosa

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960219-5

Antibiotic resistance of pathogenic staphylococci; study of five hundred strains isolated at Boston City Hospital from October, 1951, to February, 1952.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960219-5

Susceptibility of Staphylococcus aureus and Staphylococcus epidermidis to 65 antibiotics

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960219-5

Methicillin-resistant Staphylococcus aureus. Antimicrobial susceptibility.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960219-5

Methicillin-resistant Staphylococcus aureus at Boston City Hospital. Bacteriologic and epidemiologic observations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960219-5

An Outbreak of Infections Caused by Strains of Staphylococcus aureus Resistant to Methicillin and Aminoglycosides. I. Clinical Studies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960219-5

Antimicrobial susceptibility and selection of resistance among Staphylococcus epidermidis isolates recovered from patients with infections of indwelling foreign devices

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960219-5

Susceptibility and Synergy Studies of Methicillin-Resistant Staphylococcus epidermidis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960219-5

Comparison of antimicrobial susceptibility patterns among coagulase-negative staphylococci

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960219-5

Antimicrobial susceptibilities of coagulase-negative staphylococci isolated from urinary infections

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960219-5

Antimicrobial susceptibility of Staphylococcus saprophyticus and urethral staphylococci

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960219-5

Changing patterns of susceptibility of common bacterial pathogens to antimicrobial agents

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960219-5

Group A beta-hemolytic streptococci resistant to erythromycin and lincomycin.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960219-5

Synergism, killing kinetics, and antimicrobial susceptibility of group A and B streptococci

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960219-5

Drug Resistance inStreptococcus pyogenes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960219-5

Sensitivity of group A streptococci to antibiotics. Prevalence of resistance to erythromycin in Japan

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960219-5

Infections Due to Lancefield Group F and Related Streptococci (S. milleri, S. anginosus)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960219-5

In vitro antimicrobial inhibition patterns of nutritionally variant streptococci

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960219-5

Antimicrobial susceptibilities of nutritionally variant streptococci

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960219-5

Antimicrobial susceptibility of Streptococcus mutans isolated from patients with endocarditis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960219-5

Susceptibility of Streptococcus mutans to antimicrobial agents

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960219-5

Susceptibility of pneumococci to eleven antibiotics in vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960219-5

Antimicrobial Susceptibility Patterns of Streptococcus pneumoniae

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960219-5

Antimicrobial susceptibility testing of pneumococci: determination of Kirby-Bauer breakpoints for penicillin G, erythromycin, clindamycin, tetracycline, chloramphenicol, and rifampin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960219-5

Serotype distribution of penicillin-resistant pneumococci and their susceptibilities to seven antimicrobial agents

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960219-5

Antibiotic resistance and serotypes of Streptococcus pneumoniae from patients with community-acquired pneumococcal disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960219-5

Rosamicin: evaluation in vitro and comparison with erythromycin and lincomycin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960219-5

In Vitro Comparison of Rosamicin and Erythromycin Against Urinary Tract Pathogens

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960219-5

The 1970 Epidemic of Diphtheria in San Antonio

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960219-5

Observations on mode of action of erythromycin.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960219-5

Observations on bacteriostatic and bactericidal action of erythromycin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960219-5

Postantibiotic suppression of bacterial growth

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960219-5

Lack of evidence for mutation to erythromycin resistance in clinical strains of Staphylococcus aureus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960219-5

The erythromycin group of antibiotics.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960219-5

Conjugative transfer of R-plasmids from Streptococcus faecalis to Staphylococcus aureus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960219-5

Plasmid-mediated, transferable resistance to clindamycin and erythromycin in Bacteroides fragilis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960219-5

Transferable lincosamide-macrolide resistance in Bacteroides

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960219-5

Resistance to tetracycline, erythromycin, and clindamycin in the Bacteroides fragilis group: inducible versus constitutive tetracycline resistance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960219-5

Transferable resistance to clindamycin, erythromycin, and tetracycline in Clostridium difficile

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960219-5

Drug usage and antibiotic susceptibility of staphylococci

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960219-5

International Comparison of Prevalence of Resistance to Antibiotics

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960219-5

Susceptibility of Skin and Throat Strains of Group A Streptococci to Rosamicin and Erythromycin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960219-5

Susceptibility of group A beta-hemolytic Streptococcus isolates to penicillin and erythromycin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960219-5

Current antibiotic susceptibility of group A beta-hemolytic streptococci.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960219-5

Type 6 pneumococcus resistant to erythromycin and lincomycin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960219-5

Prevalence of types of Diplococcus pneumoniae and their susceptibility to 30 antibiotics.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960219-5

Streptococcus pneumoniae resistant to erythromycin and clindamycin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960219-5

Emergence of Multiply Resistant Pneumococci

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960219-5

Corynebacterium diphtheriae resistant to erythromycin and lincomycin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960219-5

Erythromycin and clindamycin resistance in Corynebacterium diphtheriae from skin lesions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960219-5

Sequence homology of clindamycin resistance determinants in clinical isolates of Bacteroides spp.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960219-5

Mechanism of Penicillin-Erythromycin Synergy on Antibiotic-Resistant Staphylococcus aureus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960219-5

Effects of subminimal inhibitory concentrations of chloramphenicol, erythromycin and penicillin on group A streptococci

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960219-5

In vitro antagonism by erythromycin of the bactericidal action of antimicrobial agents against common respiratory pathogens

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960219-5

Synergistic action of ampicillin and erythromycin against Nocardia asteroides: effect of time of incubation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960219-5

Effects of erythromycin in combination with penicillin, ampicillin, or gentamicin on the growth of Listeria monocytogenes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960219-5

Antibiotic susceptibility and synergy of clinical isolates of Listeria monocytogenes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960219-5

Combined rifampicin and erythromycin for bacterial endocarditis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960219-5

Bacteriological findings in acute maxillary sinusitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960219-5

Erythromycin Stearate in Acute Maxillary Sinusitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960219-5

Measurement of pulmonary erythromycin concentration in patients with lobar pneumonia by means of positron tomography

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960219-5

Levels of erythromycin in pulmonary tissue and bronchial mucus compared to those of amoxycillin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960219-5

A guide to use of antibiotics in patients with renal disease. A table of recommended doses and factors governing serum levels

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960219-5

THE PROTECTION OF PATHOGENIC MICROORGANISMS BY LIVING TISSUE CELLS.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960219-5

Protection of phagocytized bacteria from the killing action of antibiotics.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960219-5

Killing of Intraleukocytie Staphylococcus aureus by Rifampin: In-Vitro and In-Vivo Studies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960219-5

Cellular uptake and intracellular activity of antibiotics against Haemophilus influenzae type b

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960219-5

Antibiotic entry into human polymorphonuclear leukocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960219-5

Interaction of Intraleukocytic Bacteria and Antibiotics

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960219-5

The protection of intracellular brucella against therapeutic agents and the bactericidal action of serum

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960219-5

Commentary. Lysosomotropic agents

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960219-5

Penetration of penicillin into human phagocytes containing Neisseria gonorrhoeae: intracellular survival and growth at optimum concentrations of antibiotic

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960219-5

Clindamycin Uptake by Human Neutrophils

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960219-5

The pulmonary-alveolar macrophage (first of two parts).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960219-5

The macrophage as an effector cell

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960219-5

Effect of rifampin on nasal carriers of coagulase-positive staphylococci

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960219-5

Gram-negative anaerobic bacilli: their role in infection and patterns of susceptibility to antimicrobial agents. I. Little-known Bacteroides species

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960219-5

inferred from DOI database lookup

7 January 2021

based on heuristic

Susceptibility of Group D Streptococcus (Enterococcus) to 21 Antibiotics In Vitro, with Special Reference to Species Differences

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960219-5

inferred from DOI database lookup

7 January 2021

based on heuristic

Susceptibility of pneumococci to nine antibiotics.

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960219-5

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0025-6196(12)60219-5

1 reference

25 August 2017

1 reference

PubMed ID

3974301